NBC Securities’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$323K Sell
7,559
-3,386
-31% -$184K 0.02% 688
2026
Q1
$687K Sell
10,945
-4,998
-31% -$400K 0.05% 387
2025
Q4
$1.52M Sell
15,943
-262
-2% -$25.7K 0.11% 192
2025
Q3
$1.58M Buy
16,205
+3,607
+29% +$374K 0.12% 188
2025
Q2
$1.35M Buy
12,598
+472
+4% +$47.8K 0.11% 218
2025
Q1
$1.22M Buy
12,126
+12,115
+110,136% +$1.22M 0.1% 215
2024
Q4
$1.07K Sell
11
-11,750
-100% -$1.03M 0.1% 224
2024
Q3
$985K Buy
11,761
+2,001
+21% +$158K 0.08% 256
2024
Q2
$751K Buy
9,760
+2,393
+32% +$175K 0.07% 305
2024
Q1
$514K Buy
7,367
+311
+4% +$20K 0.05% 431
2023
Q4
$407K Sell
7,056
-118
-2% -$6.3K 0.04% 478
2023
Q3
$378K Buy
+7,174
New +$376K 0.04% 466

Other funds holding BSX

NBC Securities's BSX Position: Q2 2026 in Review

NBC Securities reduced its Boston Scientific (BSX) stake by 31% in Q2 2026, selling an estimated $184K and leaving 7,559 shares worth $323K. The position accounts for 0.02% of the portfolio, ranked #688.

NBC Securities first reported a position in BSX in Q3 2023 and has held it in 12 quarters since. The position peaked at $1.58M in Q3 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • NBC Securities held 7,559 shares of Boston Scientific worth $323K as of Q2 2026.
  • NBC Securities sold 3,386 Boston Scientific shares in Q2 2026, an estimated $184K.
  • Boston Scientific made up 0.02% of NBC Securities's portfolio in Q2 2026, its #688 holding.
  • NBC Securities first reported a position in Boston Scientific in Q3 2023 and has held it in 12 quarters since.
  • NBC Securities's Boston Scientific position peaked at $1.58M in Q3 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on NBC Securities's 13F filing for Q2 2026, filed 21 Jul 2026.